AB S T R A C T Bronchoalveolar lavage (BAL) fluid was obtained from 24 sequentially studied patients with adult respiratory distress syndrome (ARDS) for assessment of potential activating and mediating factors. Proteolytic activity of the fluids was observed by measuring cleavage of radiolabeled proteins of the contact (Hageman factor) and complement systems. Proteolytic activity was observed in 17 of 24 (71%) patients with ARDS, and BAL fluid of the 7 ARDS patients without demonstrable, active, enzyme exhibited inhibitory activity for the proteolytic activity. The enzymes cleaved Hageman factor, prekallikrein, plasminogen, high molecular weight kininogen, C4, C3, C5, and Factor B of the complement system. Cleavage of the contact system proteins producted fragments similar or identical in size to the fragments observed during activation of these molecules, although continued incubation invariably reduced the protein to small peptide fragments. None of 7 normal individuals, and 29 of 99 patients (29%) with other forms of pulmonary disease contained measurable enzymes.
substrate of neutrophil elastase, neutrophil elastase antigen was present in the BAL fluids as determined immunologically using antineutrophil elastase, al-PI was the major inhibitor in plasma, and the enzyme was inhibited by diisopropylphosphofluoridate but not chelation. In addition, purified neutrophil elastase produced cleavage fragments of proteins of the contact system similar to those of the BAL fluids.
In each of the seven BAL fluids of ARDS patients that did not reveal active elastase, al-PI was present in active form (as determined by '251-trypsin binding). In 9 of the 17 patients with active elastase in the BAL fluid, al-PI antigen was present in the fluid, but was inactive (no binding of 1251-trypsin). Immunoelectrophoretic analysis of elastase and al-PI throughout proteins in these BAL fluids revealed the presence of both elastase and al-PI that migrated with the same Rf, suggesting the presence of an enzyme-inhibitor complex. Free, inactive al-PI was also observed in these fluids.
The data reveal that in BAL fluids from all 24 patients with ARDS, leukocytic elastase and/or al-PI exist. A complex of elastase and al-PI was observed in BAL fluids, and in some cases where active enzyme and al-PI coexisted, free, but inactive al-PI was present.
INTRODUCTION
The adult respiratory distress syndrome (ARDS)' can follow a variety of insults, including non-thoracic I Abbreviations used in this paper: ARDS, adult respiratory distress syndrome; al-PI, al-proteinase inhibitor, alantitrypsin; BAL, bronchoalveolar lavage; COPD, chronic obstructive pulmonary disease; DFP, diisopropylphosphofluoridate; HF; Hageman factor; HMWK, high molecular weight kininogen; a2-M, a2-macroglobulin; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis.
causes as well as injury directly to the lung by inhalation (1) . The former appear to injure the lung via a bloodborn mechanism and the latter through direct contact at the alveolar-capillary membrane. The pathophysiology of this process is poorly understood, although the syndrome itself may be characterized by a protein-and cell-rich pulmonary edema due to increased vascular permeability in the lung (2) (3) (4) . The mediators of this increased permeability have been the subject of much study, and investigators have suggested causal relationships between proteases and this form of acute lung injury. Such has been suggested for complement, especially C5a, via neutrophil aggregation or direct microvascular injury (5) . Heflin and Brigham (6) suggested the role of blood leukocytes in this increased pulmonary vascular permeability model using sheep. Increased consumption of fibronectin with subsequent microembolization has been suggested (7), and Bone et al. (8) demonstrated increased levels of fibrin degradation products in serum from patients with active ARDS. Leuterman et al. (9) have suggested that infusion of fibrin degradation fragment D in rabbits produces lung injury similar to that occurring in the ARDS. Hyers and Franks (10) and Haynes et al. (11) have demonstrated the presence of circulating atypical fibrin fragments, thus suggesting that enhanced fibrinogenolysis is associated with ARDS.
All of these studies suggest that several agents may be responsible for increased vascular permeability observed in ARDS. The activation of Hageman factor (HF) is capable of initiating coagulation through the activation of Factor XI and of Factor VII. Furthermore, the activated product, HFa, may proteolytically convert prekallikrein to kallikrein that subsequently can lead to plasmin generation and the release of the permeability factor, bradykinin, from high molecular weight kininogen (HMKW) (12) . HFa has recently been found to increase cutaneous vascular permeability in quantities as low as 3 ng, i.e., 1/10,000th the amount of HF present in 1 ml of plasma.2 In vitro studies of the system have demonstrated that negatively charged substances may activate the system. Vascular basement membrane (13) and collagen preparations (14, 16) , bacterial lipopolysaccharides (17) , and serine protease(s) released from cultured endothelial cells (18) , are capable of cleaving and activating the system. Thus through activation of complement, contact (HF), and clotting systems of plasma a number of effector agents are generated that could mediate many of the pathologic features of ARDS.
We have undertaken studies of bronchoalveolar lavage (BAL) fluid from patients with ARDS in order to identify and characterize substances capable of activating components of the complement, contact, and clotting systems of plasma. We report herein the initial results of the definition of proteolytic activity in the BAL fluid. A portion of the data appeared in preliminary form (19) .
METHODS

Study population
BAL fluid from 130 subjects was studied. Subjects ranged in age from 19 to 78 yr; 85 were male, 45 Carcinoma. Tissue diagnosis of carcinoma of the lung (24 patients) or metastatic to lung (3 patients).
COPD. History of asthma (four patients); chronic bronchitis (two patients); emphysema (two patients).
Other. Cutaneous burn (five patients), pulmonary fibrosis (five patients), lobar collapse (six patients), hemoptysis (four patients), alveolar proteinosis (two patients), bronchocentric granulomatosis (one patient), trauma (one patient), drug overdose (one patient), pulmonary embolus (one patient), rheumatoid arthritis (one patient).
Normal. Nonsmoking adults with normal pulmonary function tests, arterial blood gases, physical examinations and chest radiographs (seven volunteers).
BAL samples and preparation BAL fluid samples were obtained through a fiberoptic bronchoscope. Lavage of a basilar segment was performed using 20 ml of normal saline of which '30-50% was recovered. These aliquots were then filtered through gauze, examined for cell count and differential, centrifuged immediately at 2,200 g for 10 min and the pellet was discarded. The supernate was then aliquoted and frozen in plastic vials at -70°C for later evaluation. The validity of the lavage procedure in sampling the area of inflammation was assessed three ways. First, the spectrum of proteins in the lavage samples of ARDS patients was compared with the spectrum of proteins in plasma in order to determine if the lavage fluid had sampled the zone of exudative proteins. Using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), the proteins in BAL fluid of all patients with ARDS were similar, if not identical, to the spectrum of proteins in plasma diluted to the same concentration as the BAL fluid. Second, the phospholipid content of the BAL fluid of the seven normal individuals was studied by Dr. Mikko Hal-man and Dr. Louis Gluck of the University of California, San Diego, and was found to have the same lecithin/spingomyelin ratio, phosphatidylglycerol, and desaturated lecithin content as normal alveolar fluid. And third, small volumes (0.5 ml) of saline containing colloidal carbon in 2% gelatin at 37°C were instilled into the bronchi at the carina of anesthetized rabbits, 4.5 cm from the pleural surface. Immediately after instillation, the lungs, showing carbonblack mottling on the pleural surface, were cooled in iced water to cause gelation of the fluid (20 s (26) and by cleavage of meth- (27) . Stacking and running gels contained 3 and 9% acrylamide, respectively. All samples before application to the gel were boiled for 4 min in the presence of 10% SDS and 2% ,B-mercaptoethanol and then applied to the gel. Following electrophoresis, gels were fixed and stained using 0.1% Coomassie Brilliant Blue R, 250. They were then destained in 10% glacial acetic acid, dried with a slab gel dryer and placed on Kodak x-omatic film (Eastman Kodak Co., Rochester, N. Y.). The molecular weight of the radiolabeled protein and cleavage fragments were determined from the relative migration of an internal standard protein analyzed on the same gel.
RESULTS
Cell count and protein analysis of BAL fluid. Leukocyte counts and protein concentration of BAL fluid from patients with ARDS are given in Table I Tables I and II; Figs.  1 and 2 ). Of the seven ARDS patients not demonstrating proteolytic enzyme, each was found to contain an inhibitor of the proteolytic activity (see below). Plasma obtained from the ARDS patients at the same time as the BAL, and diluted 1:70 in sterile saline (to yield a protein concentration approximating that of the BAL), uniformly failed to cleave components of the HF and complement systems. Analysis of the cleaved fragments of the HF and complement components revealed cleavage of HF into fragments of -50,000 and 28,000 and 31,000 Mr. Prekallikrein was cleaved to yield a radiolabeled heavy chain (the light chain was not radiolabeled), while plasminogen and HMWK were cleaved so as to reveal a heavy and light chain on occasions, but more frequently, these latter proteins were cleaved into small fragments that appeared in or near the dye front. Cleavage of C3 occurred in the a-chain, releasing a fragment of -10,000 Mr as evidenced by the estimated diminution of size of the achain on SDS-PAGE. Cleavage of C5 resulted in the appearance of only small fragments migrating at the dye front.
The effect of inhibitors of enzymes on the proteincleaving capacity of the BAL fluids. DFP was added to BAL fluids of ARDS patients at a final concentration of 1 mM 60 min before assessment of cleaving capacity in components of the HF system as performed in the previous experiments. In each of 10 cases so assayed, the DFP treatment prevented cleavage of the radioiodinated proteins. BAL fluids treated with DFP solvent maintained activity. Trasylol at 1,500 U/ml final concentration, and soybean trypsin inhibitor (60 ,g/ ml) inhibited the enzymatic activity in the lavage fluid in each of four cases of ARDS tested. Immunopurified antibodies to HF, prekallikrein, and plasmin failed to inhibit the enzymes in each of six of the BAL fluids studied. The antibodies were added in quantities sufficient to prevent completely the cleaving capacity of each active homologous en- Immunoprecipitation assays on these fluids using monospecific antielastase revealed the presence of elastase antigen in all fluids containing proteolytic enzyme activity and in several fluids of ARDS patients that failed to demonstrate such proteolytic activity (Fig. 4) . In each case, the precipitin bands coalesced with bands formed between the antibody and purified elastase. Atnibodies to neutrophil elastase were also tested for their ability to inhibit enzyme activity in the lavage fluid of patients with ARDS. In four patients with free protease in the BAL fluid, the amidolytic activity was decreased >90% by antibodies to elastase, but not by normal globulin. The antibodies, along with normal rabbit globulin, were precipitated at 35% ammonium sulfate and then subjected to acidification at pH 3.5 for 1. case in which proteolytic activity was noted using substrates of the contact system with the exception of patients 1 and 17. The BAL fluid from these two patients had been maintained for several months and had lost their capacity to cleave HF (see below). The quantity of elastase, determined with the synthetic substrate is given in Table I . The activity was unchanged in 1 mM 1,10 phenanthroline.
To examine the numbers and relative activity of enzymes in the BAL fluids of ARDS cases, [3H]DFP was incubated with the BAL fluids for 30 min at 22°C. Binding of the [3H]DFP was then determined in SDS-PAGE followed by autoradiography. In each case, binding of [3H]DFP occurred in a single area as shown in Fig. 5 . The molecular size was slightly larger than that of trypsin, having a Mr of 26,000-30,000. In some cases the zone of radioactivity formed two or three closely grouped bands. Any other zones of radioactivity were associated with large deposits of Coomassie Blue-stained protein and could not unequivocally be designated as evidence of specific DFP binding to a serine protease. Little or no protein could be seen in Coomassie Blue staining that was observed with the major zone of radioactivitv.
Effect of leukocytic elastase on HF. 1251-HF was incubated with purified human neutrophil elastase (1:50 wt/wt of elastase to HF) for 10 min at 370C and then studied using the SDS-PAGE system. Fig. 6 demonstrates that the cleavage of HF by neutrophil elastase was similar, if not identical to that producted by BAL fluids from ARDS patients. The rate of cleavage of HF by neutrophil elastase was measured during a 30-min incubation at 37°C. It was observed that longer incubation periods produced further proteolytic breakdown of 125I-HF into fragments other than the 50,000-and 28,000-mol wt components. Cleavage of 1 2 34 5 1251-HF by neutrophil elastase could be totally inhibited by pretreatment of neutrophil elastase with monospecific antibody to human neutrophil elastase.
The relationship of al-PI and leukocytic elastase in BAL fluids. With the observation that lavage fluids from patients with ARDS contained elastase protein, determined immunologically, but were without proteolytic activity, assays were performed for the presence of inhibitors in these fluids. These BAL fluids were first mixed in equal volume with other BAL fluids, known to contain active enzyme, and tested for inhibition of the proteolytic activity using '25I-HF as substrate. In each case, inhibition of the proteolytic activity was observed. Analyses were then conducted to identify the inhibitors of the enzyme of the BAL fluids. To accomplish this, 1251-trypsin (Methods) was added to each BAL fluid and assayed for binding to inhibitors in SDS-PAGE. By combining 1251-trypsin with purified al-PI and a2-macroglobulin (a2-M), the complexes of the trypsin and these two inhibitors could be identified in SDS-PAGE. The presence of active al-PI in the BAL fluids is given in Table I To analyze further the relationship of elastase enzyme and inhibitor, immunoelectrophoretic analyses were performed using antibodies to leukocytic elastase and al-PI as shown in Fig. 7 . The analysis revealed that leukocyte elastase was present, but migrated in an anodal position. al-PI in the fluid was divided between free al-PI that migrated in the anticipated region of the gel, and a more cathodally migrating form of al-PT. The position of the latter al-PI was identical to that of the anodally migrating elastase protein, suggesting a complex of the two molecules existing in these BAL fluids lacking detectable proteolytic activity. This was confirmed in double diffusion immunologic assays: an immunoprecipitin line developing between elastase in the BAL fluid and its antibody coalesced with a precipitin line developing between the al-PI in the fluid and its antibody. This was true in four cases where enzyme-inhibitor complexes were suggested by immunolectrophoresis.
Inactive al-PI in the BAL fluid of ARDS patients. In nine of the ARDS patients with proteolytic activity in the BAL fluid, the simultaneous presence of al-PI was measured immunologically. The ability of the al-PI to bind '25I-trypsin was then assessed as a measure of function of the al-PT. The binding of the 1251_ trypsin to al-PI was determined by migration of the 1251-trypsin at an Rf of the trypsin-al-PI complex, i.e., at M, 65,000. In six of the nine cases, the al-PI did not bind the '25I-trypsin (Table I) sensitivity of this technique in the case of other enzymes at low concentration is uncertain, and their presence and activity cannot be excluded. In addition, it is possible that other enzymes (including the chymotrypsinlike enzyme of neutrophils) could be bound to tissues at the site of injury in the lung and not recoverable in lavage fluid. Neutrophils are the most likely sources of the elastase. As opposed to the present findings, DFP and al-PI do not readily inhibit macrophage elastase, while chelation does (28, 30) . In addition, the elastase was detected with antibodies to neutrophil elastase. However, our data do not preclude a partial contribution from macrophages. In addition, one cannot state at present the tissue source of the neutrophil elastase, although since injury initiated primarily in the lung (e.g., with aspiration) can induce ARDS, it is probable that the elastase is released in the pulmonary tissues at least in some cases of ARDS. Neutrophils are present in the lung in ARDS although their numbers are not always great. It is of interest that the presence of free elastase was found to be more frequent in ARDS than in COPD or in bronchopneumonia. While this may relate to sampling error, it may suggest that in ARDS the release of enzymes by the leukocytes is heightened, or that inhibition of the released enzyme is diminished.
In all cases where protease activity was not detected in the BAL fluid of ARDS patients, al-PI inhibitor was found, both immunologically and by function. Complexing of the al-PI and leukocytic elastase was suggested in immunoelectrophoresis in which a comigration of elastase and al-PI appeared in the beta 1 region, i.e., in a position distinct from either enzyme or inhibitor in their free state. The beta 1 position was identical to that occurring when purified elastase and al-PI were mixed before electrophoretic separation.
Our observafions on the presence of elastase and al-PI in BAL of patients with ARDS is similar to that reported by Lee et al. (31) , which appeared while this manuscript was in preparation. These authors observed that BAL fluid of 12 of 23 patients exhibited elastase activity above background level using an amidolytic assay, and by lysis of elastin. All patients' lavage fluid contained al-PI, and four with low elastase levels possessed high levels of al-PI activity as measured by trypsin binding.
The source of the elastase appeared to be the neutrophil. Nevertheless, total leukocyte (Table II) and differential cell counts (data not presented) of the lavage fluids failed to reveal a clear relationship of the concentration of neutrophils and the levels of elastase. This could be explained by adherence of the neutrophils in the lung tissue or the placement of these cells in the lung parenchyma in different cases.
Presence of inhibited al-PI in BAL fluid in ARDS.
Of potential importance in the pathogenesis of the disease was the observation in the present report that in seven cases in which active enzyme and al-PI were found together, the al-PI was inactive. That the inactive al-PI was free, i.e., not bound by enzyme, was revealed in immunoelectrophoresis. The factors responsible for the inactivation of free al-PI are not clear. However among the possible mechanisms that could account for the inactivation is contact with oxidizing agents. al-PI activity is inhibited by oxidation of a methionyl residue at the reactive center of the molecule (32) (33) (34) (35) . Such a mechanism has been proposed to explain the loss of al-PI in smokers (36) (37) (38) . Assuming that neutrophils and macrophages are stimulated to release elastase in ARDS, it is altogether possible that they generate superoxide anion, H202, and 0OH-as well. In addition, myeloperoxidase, which is released from stimulated leukocytes, inactivates al-PI in the presence of H202 and chloride ion (39) (40) (41) . Each of these could bring about the oxidation of the methionyl residue in the reactive center of the al-PI.
Mechanisms of injury of pulmonary tissue in ARDS. Injury of the lung tissue in ARDS could result from direct action of the proteinases on the vascular basement membranes (42, 43) , elastin (44) , collagen (45) , and structural elements of the pulmonary tissues (46) . Infusion of elastase has been shown to produce severe injury to the lung (47, 48) . In addition, the enzyme(s) could cause increased permeability of the blood vessels by activation of components of the contact and/or complement systems (49) . In a separate paper, we will offer evidence that activation of HF does follow enzymatic cleavage by BAL fluid of ARDS patients and that C5a can be detected in the fluid. Activation of HF could bring about fibrin formation through the intrinsic and extrinsic clotting systems.
Another possibility that must be considered is that the generation of free radicals derived from molecular oxygen may be responsible for a portion of the injury. Their presence may be reflected in the finding that free al-PI is inhibited in the BAL fluid of ARDS patients as noted above. The capacity of oxygen free radicals and their metabolites to induce injury of the lung of rats has recently been shown by Johnson et al. (50) . Superimposition of oxygen therapy in ARDS must also be taken into consideration for its contribution to injury through oxidizing mechanisms.
BAL has been performed by others using volumes ranging from 30 plus 30 plus 40 ml (sequential lavages) (51) to 50 ml or more. How likely is it that our lavage volume of 20 ml, 30 -50% of which is recovered, samples the gas exchanging portion of the lung?
We have shown in the rabbit that as little as 0.5 ml of 2% gelatin containing colloidal carbon administered in the mainstem bronchus of either an excised or in vivo lung reaches the alveolar spaces. Scaling this experiment to human dimensions would suggest that our lavage volume is more than sufficient to reach the alveoli.
The morphometric analysis of K. Horsefield and C. Cumming (52) and information on bronchial and bronchiolar anatomy (53) allow calculation of the anatomic dead space subtended by the segmental bronchus in which our bronchoscope was wedged. A volume of the central airways (lobar and mainstem bronchi) of 12.4 ml, subtracted from an anatomic dead space of 71 ml below the carina, leaves 58.6 ml of dead space beyond the segmental bronchial orifices. Thus, on the average, 3.1 ml of dead space exists beyond the orifice of each segmental bronchus. Recovery of 6-10 ml of lavage fluid administered suggests that 48-69% of the fluid recovered has reached beyond the distal lobular bronchiole. Thus, calculations of the recovered volume indicate that the majority of the fluid has reached at least the level of the respiratory bronchiole. Alveolar structures arising from the respiratory bronchiole (54) are almost certainly bathed by this fluid. Mixing with fluid in more distal alveolar ducts and alveoli will be enhanced by cardiac and ventilatory oscillations.
